Lamond Capital Partners as of Dec. 31, 2015
Portfolio Holdings for Lamond Capital Partners
Lamond Capital Partners holds 7 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oracle Corporation (ORCL) | 27.3 | $18M | 500k | 36.53 | |
| Abbvie (ABBV) | 26.6 | $18M | 300k | 59.24 | |
| Puma Biotechnology (PBYI) | 25.9 | $17M | 221k | 78.40 | |
| Amgen (AMGN) | 18.2 | $12M | 75k | 162.33 | |
| Ignyta | 0.9 | $626k | 47k | 13.40 | |
| Zeltiq Aesthetics | 0.7 | $460k | 16k | 28.54 | |
| Immunomedics | 0.5 | $307k | 100k | 3.07 |
